Maravai Lifesciences Holdings 

Maravai Lifesciences Holdings 

Yahoo Finance • 5 days ago

A cancer vaccine years in the making just proved itself

On August 19, Merck (MRK) said its personalized cancer vaccine had proved effective in a large, late-stage melanoma study, and Wall Street responded fast. Merck shares closed up about 12.5% that day, one of the biggest single-day moves th... Full story

Yahoo Finance • 8 days ago

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index decreasing 0.9% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 22 days ago

Maravai outlines $33M-$35M 2026 adjusted EBITDA outlook while maintaining $205M-$215M revenue range

Earnings Call Insights: Maravai LifeSciences (MRVI) Q2 2026 MANAGEMENT VIEW * "We are very pleased with our second quarter performance, which builds on the strong momentum we established in the first quarter." (CEO & Director Bernd Bru... Full story

Yahoo Finance • 3 months ago

This is why Maravai Lifesciences Holdings Inc. (MRVI) is a Top penny Stock in the Top Investors Portfolio

Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) is one of the top penny stocks to buy in investors’ stock portfolio. On May 7, Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) affirmed a strong start to the year, driven by strong demand i... Full story

Yahoo Finance • 4 months ago

Maravai (MRVI) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATE May 7, 2026 CALL PARTICIPANTS Chief Executive Officer — Bernd Brust Chief Financial Officer — Rajesh Asarpota Chief Scientific Officer — Chanfeng Zhao Investor Relations — Debra Hart Need a quote fr... Full story

Yahoo Finance • 8 months ago

Aptamer Enters Licensing Agreement With Alphazyme

(RTTNews) - Aptamer Group (P0J.F, APTA.L) and Alphazyme, a Maravai LifeSciences (MRVI) company, have entered into a licensing agreement for a developed Optimer for use in hot-start PCR applications. Aptamer grants Alphazyme a non-exclusive... Full story

Yahoo Finance • 10 months ago

Maravai LifeSciences Holdings Non-GAAP EPS of -$0.08 in-line, revenue of $41.6M misses by $7.42M

* Maravai LifeSciences Holdings press release [https://seekingalpha.com/pr/20297746-maravai-lifesciences-reports-third-quarter-2025-financial-results] (MRVI [https://seekingalpha.com/symbol/MRVI]): Q3 Non-GAAP EPS of -$0.08 in-line. *... Full story

Yahoo Finance • 10 months ago

MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Maravai LifeSciences be... Full story

Yahoo Finance • 11 months ago

Tuesday's ETF Movers: FIG, ITB

In trading on Tuesday, the Simplify Macro Strategy ETF is outperforming other ETFs, up about 7.1% on the day. Components of that ETF showing particular strength include shares of Maravai Lifesciences Holdings, up about 7.2% and shares of... Full story

Yahoo Finance • 11 months ago

MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Maravai LifeSciences be... Full story

Yahoo Finance • 12 months ago

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Maravai LifeSciences be... Full story

Yahoo Finance • last year

Maravai signals $50M annualized cost reduction plan as leadership targets positive EBITDA in 2026

Earnings Call Insights: Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 MANAGEMENT VIEW * CEO Bernd Brust opened his first earnings call by noting, "I came into this role with a clear understanding that realizing Maravai's full pote... Full story

Yahoo Finance • last year

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base business revenue, which excludes revenue from high-volume CleanCap® for commercializ... Full story

Yahoo Finance • last year

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 fi... Full story

Yahoo Finance • last year

Maravai LifeSciences appoints Deloitte as new auditor, replaces EY

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) announced Friday that its Audit Committee has approved the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending Dec... Full story

Yahoo Finance • last year

Johnson Fistel, PLLP Continues Investigation Claims on Behalf of Quantum Computing Inc. (QUBT), AppLovin Corporation (APP), Skyworks Solutions, Inc. (SWKS), and Maravai LifeSciences Holdings, Inc. (MRVI) Long-Term Shareholders

SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, is investigating potential violations of federal and state securities laws by certain officers and directors of Quantum Computing Inc. (NASDAQ: QUBT), AppLovin Corporatio... Full story

Yahoo Finance • last year

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Maravai LifeSciences be... Full story

Yahoo Finance • last year

Johnson Fistel, PLLP Investigates Quantum Computing, AppLovin, Skyworks Solutions, and Maravai LifeSciences

SAN DIEGO, July 02, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Quant... Full story

Yahoo Finance • last year

Maravai LifeSciences stock rating reiterated amid leadership changes

Investing.com - William Blair maintained its Market Perform rating on Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) Tuesday following significant leadership changes at the company. According to InvestingPro data, the company’s shares ha... Full story

Yahoo Finance • last year

Maravai Lifesciences appoints Rajesh Asarpota as chief financial officer

* Maravai LifeSciences (NASDAQ:MRVI [https://seekingalpha.com/symbol/MRVI]) announced that Rajesh Asarpota has been appointed executive vice president and chief financial officer effective June 30, 2025. * He will succeed Kevin Herde,... Full story